1163693-01-3 Usage
Uses
Used in Pharmaceutical Industry:
2-chloro-3-iodo-4-methoxypyridine is used as a key intermediate in the synthesis of pharmaceuticals for its ability to be functionalized into a variety of bioactive compounds. Its unique functional groups facilitate the development of new drugs with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, 2-chloro-3-iodo-4-methoxypyridine is utilized as a precursor for the synthesis of agrochemicals, contributing to the creation of novel pesticides and other crop protection agents that can enhance agricultural productivity and crop protection.
Used in Organic Synthesis:
2-chloro-3-iodo-4-methoxypyridine is employed as a versatile building block in organic synthesis, allowing for the construction of complex organic molecules with potential applications in various fields, including materials science and specialty chemicals.
Used in Medicinal Research:
As a valuable tool in medicinal research, 2-chloro-3-iodo-4-methoxypyridine aids in the exploration of new chemical entities with potential therapeutic effects, contributing to the advancement of drug discovery and development.
Used in Agricultural Research:
In agricultural research, 2-chloro-3-iodo-4-methoxypyridine is used to investigate new compounds for enhancing crop resistance to pests and diseases, thereby supporting sustainable agriculture practices.
Check Digit Verification of cas no
The CAS Registry Mumber 1163693-01-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,6,3,6,9 and 3 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1163693-01:
(9*1)+(8*1)+(7*6)+(6*3)+(5*6)+(4*9)+(3*3)+(2*0)+(1*1)=153
153 % 10 = 3
So 1163693-01-3 is a valid CAS Registry Number.
1163693-01-3Relevant academic research and scientific papers
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
-
Page/Page column 117, (2015/01/16)
The present invention provides, in part, compounds of Formula (I) and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating D1 -mediated (or D1 -associated) disorders including, e.g., schizophrenia (e.g., its cognitive and negative symptoms), cognitive impairment (e.g., cognitive impairment associated with schizophrenia, AD, PD, or pharmacotherapy therapy), age-related cognitive decline, dementia, and Parkinson's disease.
QUINAZOLINONE DERIVATIVES AS VIRAL POLYMERASE INHIBITORS
-
, (2011/04/19)
Compounds of formula I: (I) wherein X, R2, R3, R5 and R6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.
